Evrofarma SA

Athens Stock Exchange EVROF.AT

Evrofarma SA Price to Sales Ratio (P/S) on January 14, 2025: 0.51

Evrofarma SA Price to Sales Ratio (P/S) is 0.51 on January 14, 2025, a 36.51% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.

Evrofarma SA 52-week high Price to Sales Ratio (P/S) is 0.56 on January 09, 2025, which is 9.15% above the current Price to Sales Ratio (P/S).
Evrofarma SA 52-week low Price to Sales Ratio (P/S) is 0.36 on January 18, 2024, which is -29.92% below the current Price to Sales Ratio (P/S).
Evrofarma SA average Price to Sales Ratio (P/S) for the last 52 weeks is 0.43.

Key data

Date	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield	Free Cash Flow Yield

Athens Stock Exchange: EVROF.AT

Evrofarma SA

CEO	Mr. Paschalis H. Papazilakis
IPO Date	June 13, 2000
Location	Greece
Headquarters	1st km Didymoteicho – Orestiada
Employees	166
Sector	Consumer Staples
Industries Dairy & Milk

Description

Evrofarma SA produces and sells dairy products in Greece. It offers milk, yoghurt, cheese, and fermented beverages. The company also exports its products. Evrofarma SA was founded in 1991 and is headquartered in Didymoteicho, Greece.

Key trends

Past 5 years